4a6l: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:4a6l.png|left|200px]] | [[Image:4a6l.png|left|200px]] | ||
{{STRUCTURE_4a6l| PDB=4a6l | SCENE= }} | {{STRUCTURE_4a6l| PDB=4a6l | SCENE= }} | ||
===beta-tryptase inhibitor=== | ===beta-tryptase inhibitor=== | ||
{{ABSTRACT_PUBMED_22192588}} | {{ABSTRACT_PUBMED_22192588}} | ||
==About this Structure== | ==About this Structure== | ||
[[4a6l]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4A6L OCA]. | [[4a6l]] is a 4 chain structure of [[Tryptase]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4A6L OCA]. | ||
==See Also== | |||
*[[Tryptase|Tryptase]] | |||
==Reference== | ==Reference== |
Revision as of 09:40, 27 July 2012
beta-tryptase inhibitorbeta-tryptase inhibitor
Template:ABSTRACT PUBMED 22192588
About this StructureAbout this Structure
4a6l is a 4 chain structure of Tryptase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Liang G, Aldous S, Merriman G, Levell J, Pribish J, Cairns J, Chen X, Maignan S, Mathieu M, Tsay J, Sides K, Rebello S, Whitely B, Morize I, Pauls HW. Structure-based library design and the discovery of a potent and selective mast cell beta-tryptase inhibitor as an oral therapeutic agent. Bioorg Med Chem Lett. 2012 Jan 15;22(2):1049-54. Epub 2011 Dec 7. PMID:22192588 doi:10.1016/j.bmcl.2011.11.119